Log in met Medi-Access

Wilt u het gehele artikel lezen?
Log in met Medi-Access om verder te lezen

Amgen’s biosimilar delivers impressive phase 3 results for psoriasis compared to Janssen’s Stelara

PMLiVE | Geplaatst op 20.04.2022 14:32

The biosimilar was seen to have no clinically meaningful differences to Stelara